Tessa Romero
Stock Analyst at J.P. Morgan
(4.27)
# 1,427
Out of 5,058 analysts
211
Total ratings
44.4%
Success rate
12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tessa Romero
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Initiated: Buy | $700 | $248.24 | +181.99% | 1 | Oct 15, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | n/a | $63.43 | - | 35 | Oct 14, 2026 | |
| DFTX Definium Therapeutics | Initiated Coverage: Buy | $84 | $34.24 | +145.33% | 1 | Oct 9, 2026 | |
| WVE Wave Life Sciences | Downgraded: Hold | n/a | $3.09 | - | 1 | Sep 23, 2026 | |
| SRRK Scholar Rock Holding | Rated: Buy | $70 | $39.60 | +76.77% | 12 | Sep 21, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $82 | $33.90 | +141.89% | 17 | Sep 19, 2026 | |
| BHVN Biohaven | Reiterated: Buy | n/a | $10.93 | - | 15 | Sep 13, 2026 | |
| DYN Dyne Therapeutics | Downgraded: Sell | $10 | $15.04 | -33.51% | 15 | Sep 8, 2026 | |
| EWTX Edgewise Therapeutics | Rated: Buy | $53 → $60 | $37.02 | +62.07% | 22 | Aug 20, 2026 | |
| SEPN Septerna | Reiterated: Buy | $38 → $48 | $36.32 | +32.16% | 4 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.01 | - | 8 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $23 → $20 | $7.17 | +178.94% | 5 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $9 | $3.42 | +163.16% | 11 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.09 | +330.62% | 2 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.63 | +242.21% | 4 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $31 | $30.94 | +0.19% | 17 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.67 | - | 3 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $16.68 | +151.80% | 2 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.3545 | - | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $2.21 | - | 2 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $34 | $19.25 | +76.62% | 19 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.13 | - | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $2.42 | n/a | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.33 | n/a | 4 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $10 | $9.56 | n/a | 2 | Jul 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $46.82 | n/a | 1 | Nov 9, 2020 |
Praxis Precision Medicines
Oct 15, 2026
Initiated: Buy
Price Target: $700
Current: $248.24
Upside: +181.99%
Cytokinetics
Oct 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $63.43
Upside: -
Definium Therapeutics
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $84
Current: $34.24
Upside: +145.33%
Wave Life Sciences
Sep 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.09
Upside: -
Scholar Rock Holding
Sep 21, 2026
Rated: Buy
Price Target: $70
Current: $39.60
Upside: +76.77%
Xenon Pharmaceuticals
Sep 19, 2026
Reiterated: Buy
Price Target: $82
Current: $33.90
Upside: +141.89%
Biohaven
Sep 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.93
Upside: -
Dyne Therapeutics
Sep 8, 2026
Downgraded: Sell
Price Target: $10
Current: $15.04
Upside: -33.51%
Edgewise Therapeutics
Aug 20, 2026
Rated: Buy
Price Target: $53 → $60
Current: $37.02
Upside: +62.07%
Septerna
Aug 19, 2026
Reiterated: Buy
Price Target: $38 → $48
Current: $36.32
Upside: +32.16%
Aug 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.01
Upside: -
Aug 14, 2026
Rated: Buy
Price Target: $23 → $20
Current: $7.17
Upside: +178.94%
Aug 14, 2026
Reiterated: Hold
Price Target: $8 → $9
Current: $3.42
Upside: +163.16%
Jun 29, 2026
Reiterated: Buy
Price Target: $9
Current: $2.09
Upside: +330.62%
Jun 25, 2026
Reiterated: Buy
Price Target: $9
Current: $2.63
Upside: +242.21%
Jun 11, 2026
Rated: Hold
Price Target: $31
Current: $30.94
Upside: +0.19%
Jun 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.67
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: $42
Current: $16.68
Upside: +151.80%
May 26, 2026
Reiterated: Sell
Price Target: n/a
Current: $0.3545
Upside: -
Apr 2, 2026
Reiterated: Sell
Price Target: n/a
Current: $2.21
Upside: -
Mar 4, 2026
Rated: Buy
Price Target: $31 → $34
Current: $19.25
Upside: +76.62%
Nov 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.13
Upside: -
Oct 23, 2024
Downgraded: Sell
Price Target: n/a
Current: $2.42
Upside: n/a
Oct 18, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.33
Upside: n/a
Jul 13, 2022
Downgraded: Hold
Price Target: $22 → $10
Current: $9.56
Upside: n/a
Nov 9, 2020
Downgraded: Hold
Price Target: n/a
Current: $46.82
Upside: n/a